Stelian Olar
NFP, Brexit, US-China And The Pandemic Send Mixed Signals To Traders
The week starts with mixed sentiments.
Nonfarm payrolls raise stimulus expectations.
New US sanctions against Chinese officials affect global investor confidence.
Brexit talks...
GBP/USD Analysis: Brexit Back in Focus As Deal Talks Drag on
GBP/USD selling continues for the second day.
Brexit headlines main driver for Cable.
Global risk sentiment is a shade weaker than last week...
USD/CAD Eyes Job Numbers For a Pause In Selling
The pair is consolidating near the lowest point since October 2018.
US Fed, Fiscal stimulus expected, weakens the greenback.
Oil prices lift CAD,...
AUD Grows Stronger As Risk Bulls March-on
Vaccine optimism is a big boost for risk assets.
Global sentiments favour risk-bulls.
Australian GDP supports strength in the currency.
RBI policy awaited.
The...
Greenback Awaits Clarity As Too Many Factors Weigh-In
The pandemic progress and US-China trade tensions weigh on the risk mood. At the same time, the hopes surrounding the fiscal stimulus and coronavirus...
USD/JPY Recent Bounce under Threat?
USD/JPY falls after the early rise.
Vaccine optimism weighs on JPY, aiding the pair.
Traders eye US data for further clues.
The USD/JPY trades...
AUD/USD Technical Outlook: Ready To Test 0.7400
AUD/USD bulls in command a second consecutive day.
Hourly bullish crossover formed, RSI above the neutral point.
Australian GDP favours the up-move.
The AUD/USD...
GBP/USD Steady, UK Ready For Coronavirus Vaccine
Vaccine from BioNTech SE and Pfizer receives UK approval for rollout.
Final advice for vaccine distribution soon, rollout from next week.
GBP/USD didn't...
FX Daily Outlook: Brexit and Vaccine Hopes to Shape the Day
Vaccine hopes abound.
The US-dollar selling in vogue.
Brexit-deal hopes to help GBP/USD bulls.
Vaccine hopes and Brexit-deal optimism are driving the markets up...
CAD Rise on Cards As Economy Booms
Vaccine news and Chinese data cheer risk bulls.
CAD bulls supported as the economy grew strong.
USD/CAD weak, near yearly lows.
The pharmaceutical company...









